Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.

Article English OPEN
Zhuo Ma; Erica Lasek-Nesselquist; Jackson Lu; Ryan Schneider; Riddhi Shah; George Oliva; Janice Pata; Kathleen McDonough; Manjunath P Pai; Warren E Rose; George Sakoulas; Meenakshi Malik;
  • Publisher: Public Library of Science (PLoS)
  • Journal: PLoS ONE,volume 13,issue 6 (issn: 1932-6203, eissn: 1932-6203)
  • Related identifiers: pmc: PMC5991675, doi: 10.1371/journal.pone.0198366
  • Subject: Microbial Control | Computational Biology | Molecular Biology | Microbial pathogens | Research Article | Bacteria | Pathology and laboratory medicine | Methicillin-resistant Staphylococcus aureus | Antimicrobials | Genomic Libraries | Genetics | Pathogens | Microbial Physiology | Antimicrobial Resistance | Antibiotic Resistance | Genome Analysis | Molecular Biology Techniques | Staphylococcus | Pharmacology | Vancomycin | Genomics | Staphylococcus aureus | Sequencing Techniques | Biology and Life Sciences | Drugs | Developmental Biology | Microbial Growth and Development | Research and Analysis Methods | Microbiology | Medicine | Bacterial pathogens | Bacterial Growth | Medical microbiology | Q | R | Science | Organisms | Genome Sequencing | Medicine and Health Sciences | Antibiotics | Gene Expression
    mesheuropmc: fungi

The extensive use of daptomycin (DAP) for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the last decade has led to the emergence of DAP non-susceptible (DNS) Staphylococcus aureus strains. A better understanding of the molecular changes u... View more
Share - Bookmark